Benjamin J. Zeskind - Aug 3, 2021 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
President and CEO, Director, 10%+ Owner
Signature
By: /s/ Michael D. Bookman, Attorney-in-Fact for Benjamin J. Zeskind
Stock symbol
IMRX
Transactions as of
Aug 3, 2021
Transactions value $
$31,470
Form type
4
Date filed
8/4/2021, 06:06 AM
Previous filing
Jul 29, 2021
Next filing
Sep 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Conversion of derivative security +49.1K +1.93% 2.6M Aug 3, 2021 Direct F1
transaction IMRX Class A Common Stock Purchase $31.5K +2.1K +0.08% $15.00 2.6M Aug 3, 2021 Direct
holding IMRX Class A Common Stock 545K Aug 3, 2021 See Foonote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Series A Preferred Stock Conversion of derivative security -40.9K -100% 0 Aug 3, 2021 Class A Common Stock 40.9K Direct F1
transaction IMRX Series B Preferred Stock Conversion of derivative security -8.17K -100% 0 Aug 3, 2021 Class A Common Stock 8.17K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.
F2 Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.